Home/Pipeline/Type 2 Diabetes Study (Oral Insulin)

Type 2 Diabetes Study (Oral Insulin)

Type 2 Diabetes

Phase 2-4Coming Soon

Key Facts

Indication

Type 2 Diabetes

Phase

Phase 2-4

Status

Coming Soon

Company

Oviedo Medical Research

About Oviedo Medical Research

Oviedo Medical Research is a private, service-based clinical research company founded in 2010, serving as a site management organization for later-stage (Phase II-IV) clinical trials. It leverages its state-of-the-art facility in Central Florida to enroll patients for studies sponsored by large pharmaceutical and biotech partners, with a current pipeline emphasizing GLP-1 therapies for weight loss and diabetes, as well as diagnostic devices. The company's business model is built on providing clinical trial services, generating revenue through research contracts, and it occupies a niche in the growing clinical research outsourcing market.

View full company profile

Therapeutic Areas

Metabolic Disease Type 2 Diabetes Obesity

Other Type 2 Diabetes Drugs

Drug	Company	Phase	Status
Diabetes Management Gel	Gelteq Limited	Formulation Development	Active
Tolimidone	Biodexa Pharmaceuticals	Phase 2	Acquired Asset
Generic Semaglutide Injection (Obeda)	Dr. Reddy's Laboratories	Approved	Launched in India
BioChaperone® Lispro	Adocia	Phase 3	Active
BioChaperone® Combo (Insulin Glargine / Lixisenatide)	Adocia	Phase 2	Active
Metformin API	USV Biologics Division	Commercial	Active
Empagliflozin	Azico Biophore	Commercial	Active
Sitagliptin Intermediate	AR Life Science	Commercial	Active
AJN003 (LuCI™)	AltrixBio	Pre-clinical	Advancing to Phase 1 (planned 2026)
Sitagliptin Phosphate Polymorph	Morepen Laboratories	Pre‑clinical	Active
Hepatic Denervation for Type 2 Diabetes	Metavention	Feasibility	Active
MVD-1 (SANA)	Eolo Pharma	Discovery	Active